Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Shenogen Pharma Group Ltd.

http://www.shenogen.com.cn

Latest From Shenogen Pharma Group Ltd.

Deal Watch: Lilly, AbCellera Partner To Attempt Rapid COVID-19 Antibody Development

Partnership will combine AbCellera’s screening of antibodies to the virus with Lilly’s development, commercial capabilities. Vir adds Biogen tie-up to its ongoing coronavirus efforts.

Deals Coronavirus COVID-19

China Investment Roundup: Spotlight On Oncology

Early-stage venture capital funding in China continued to rise in Q3, while big Chinese companies are investing in foreign firms with an eye on access to new products and market expansion. Several healthcare funds were also set up to tap into emerging opportunities.

BioPharmaceutical China

Shenogen’s Icaritin: A New First-Line Therapy For HCC?

Preliminary data from a Phase II study has unveiled promising results for Shenogen’s icaritin, a plant-derived product being studied as a possible therapy for hepatocellular carcinoma. The drug’s safety profile makes it particularly appealing, says the Chinese startup’s chief business officer.

BioPharmaceutical China

Asia Spotlight: China’s First TCM Law Excites Industry Looking For Cheer

A long-awaited new law that could greatly enlarge the market for traditional Chinese medicines has prompted domestic drug makers in China to race to develop new products, but could it also hurt multinational drug companies in the country?

BioPharmaceutical China
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Beijing Shenogen Pharma Group Ltd.
    • Xinogen (Hong Kong) Pharma Co. Ltd.
UsernamePublicRestriction

Register